Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
W. Michael Flanagan currently holds 31,974 shares of Avidity Biosciences, Inc. (RNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, W. Michael Flanagan has been a net seller of RNA stock. They have purchased $0 and sold $6.8M worth of shares.
W. Michael Flanagan's most recent insider trade was on Sep 18, 2026, when they sold 22,812 shares at $8.95 per share.
W. Michael Flanagan serves as Executive at Avidity Biosciences, Inc. (RNA). They have executed 26 insider transactions totaling $6.8M over their tenure at the company.
W. Michael Flanagan holds the position of Executive at Avidity Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
W. Michael Flanagan has shown a selling trading pattern, with $0 in total purchases and $6.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by W. Michael Flanagan was on Sep 11, 2024, when they sold $2.5M worth of RNA shares. This transaction involved 62,500 shares at $40.40 per share.
W. Michael Flanagan currently owns 31,974 shares of Avidity Biosciences, Inc. (RNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of W. Michael Flanagan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. W. Michael Flanagan has 26 Form 4 filings on record as an insider at Avidity Biosciences, Inc..
Set alerts for W. Michael Flanagan and 40,000+ other insiders.